Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, P. C.
Right arrow Articles by Hughes, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, P. C.
Right arrow Articles by Hughes, J.

Journal of the American Society of Nephrology, Vol 6, 1125-1133, Copyright © 1995 by American Society of Nephrology


REVIEWS

Polycystic kidney disease. 1: Identification and analysis of the primary defect

PC Harris, CJ Ward, B Peral and J Hughes

The identification of the primary defect in autosomal dominant polycystic kidney disease (ADPKD) by biochemical methods has proved difficult because of the complexity of the cystic kidney. However, by the use of the genetic method of positional cloning, a gene accounting for approximately 85% of ADPKD, PKD1, has now been identified in the chromosome region 16p13.3. Its exact location was pinpointed because it was bisected by a chromosome translocation; members with the balanced exchange had PKD1. The PKD1 gene encodes an approximately 14-kb transcript, but full characterization was complicated, because most of the gene lies in a genomic region that is duplicated elsewhere on chromosome 16; the duplicate area encodes three genes with substantial homology to PKD1. At present, only seven mutations of PKD1 have been characterized and these are clustered in the nonduplicated, 3' end of the gene. However, a number of patients with large deletions of the PKD1 and adjacent tuberous sclerosis 2 (TSC2) genes, who have tuberous sclerosis and severe childhood-onset polycystic kidney disease, have also been described. Recently, the entire sequence of the PKD1 transcript and the genomic region containing the gene have been determined. The PKD1 gene covers approximately 52 kb of genomic DNA and is divided into 46 exons. The transcript is approximately 14.15 kb, and the predicted protein polycystin is 4302/3 amino acids with a calculated mass of approximately 460 kd. Polycystin contains several distinctive extracellular domains, including a flank-leucine rich repeat-flank domain, a C-type lectin, 16 approximately 85-amino-acid units that are similar to immunoglobulin repeats, four fibronectin Type III-related domains, and a low-density lipoprotein A domain. The C- terminal third of the protein has multiple hydrophobic regions, and modeling of this region suggests the presence of many transmembrane domains and a cytoplasmic C terminus. Hence, polycystin is probably an integral membrane protein with multiple extracellular domains that are involved in cell-cell and/or cell-matrix interactions. The ADPKD phenotype suggests that polycystin may play a role in cell-matrix communication, which is important for normal basement membrane production and for controlling cellular differentiation.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Condac, R. Silasi-Mansat, S. Kosanke, T. Schoeb, R. Towner, F. Lupu, R. D. Cummings, and M. E. Hinsdale
Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis
PNAS, May 29, 2007; 104(22): 9416 - 9421.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. Rodova, M. R. Islam, K. R. Peterson, and J. P. Calvet
Remarkable Sequence Conservation of the Last Intron in the PKD1 Gene
Mol. Biol. Evol., October 1, 2003; 20(10): 1669 - 1674.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. C. Parnell, B. S. Magenheimer, R. L. Maser, C. A. Zien, A.-M. Frischauf, and J. P. Calvet
Polycystin-1 Activation of c-Jun N-terminal Kinase and AP-1 Is Mediated by Heterotrimeric G Proteins
J. Biol. Chem., May 24, 2002; 277(22): 19566 - 19572.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C R V Tomson
Recent advances: Nephrology
BMJ, January 8, 2000; 320(7227): 98 - 101.
[Full Text]


Home page
J. Biol. Chem.Home page
J. M. Zapata, K. Pawlowski, E. Haas, C. F. Ware, A. Godzik, and J. C. Reed
A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-associated Factor Domains
J. Biol. Chem., June 22, 2001; 276(26): 24242 - 24252.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP